Table 1.
Demographics and clinical characteristics of all patients
| Characteristics | Initial staging | Restaging |
|---|---|---|
| Number of patients (n=50) | 17 | 33 |
| Age (years) | ||
| Mean | 67.6 | 66.3 |
| Range | 55-75 | 51-77 |
| PSA level at the time of MRI/PET/bone scan (ng/ml) | ||
| Mean | 16.9 | 57 |
| Range | 4.48-67.7 | 0.08-947.64 |
| Gleason score at the time of MRI/PET/bone scan | ||
| Median | 8 | 7 |
| Range | 6-10 | 6-9 |
| SUVmax of primary lesion | ||
| Mean | 5.8 | 6.3 |
| Range | 2.1-11.2 | 1.2-16.9 |
PSA: Prostate-specific antigen, MRI: Magnetic resonance imaging, PET: Positron emission tomography, SUVmax: Maximum standardized uptake value